IDEXX Laboratories Inc.

IDXX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $4.30B $3.90B $3.66B $3.39B $3.22B $2.71B $2.41B $2.21B
Companion Animal Group $3.36B $3.08B $2.90B $2.39B $2.12B $1.92B
Water $171.7M $157.2M $141.6M $127.8M $127.9M $120.3M
Livestock Poultry and Dairy $109.1M $122.2M $144.3M $136.4M $130.6M $131.5M
Other $16.7M $24.1M $32.1M $54.2M $28.8M $39.3M
Cost of Revenue $1.64B $1.52B $1.47B $1.36B $1.33B $1.14B $1.04B $971.7M
Gross Profit $2.66B $2.38B $2.19B $2.00B $1.89B $1.57B $1.37B $1.24B
Gross Margin 61.8% 61.0% 59.8% 59.2% 58.8% 58.0% 56.7% 56.1%
Operating Expenses
Research & Development $251.2M $219.8M $191.0M $254.8M $161.0M $141.2M $133.2M $117.9M
SG&A Expense $404.8M $442.3M $335.8M $326.2M $309.7M $300.8M $261.3M $244.9M
Operating Income $1.36B $1.13B $1.10B $898.8M $932.0M $694.5M $552.8M $491.3M
Operating Margin 31.6% 29.0% 30.0% 26.5% 29.0% 25.7% 23.0% 22.2%
Interest Expense $41.6M $39.9M $29.8M $33.1M $31.1M $34.7M
Pretax Income $1.32B $1.11B $1.06B $860.0M $902.7M $662.0M $522.2M $457.7M
Income Tax Expense $264.7M $222.0M $216.1M $180.9M $157.8M $79.9M $94.4M $80.7M
Net Income $1.06B $887.9M $845.0M $679.1M $744.8M $581.8M $427.7M $377.0M
Net Margin 24.6% 22.8% 23.1% 20.0% 23.2% 21.5% 17.8% 17.0%
EPS (Basic) $13.17 $10.77 $10.17 $8.12 $8.74 $6.82 $4.97 $4.34
EPS (Diluted) $13.08 $10.67 $10.06 $8.03 $8.60 $6.71 $4.89 $4.26
Shares Outstanding (Basic) 80.4M 82.5M 83.1M 83.6M 85.2M 85.3M 86.1M 86.9M
Shares Outstanding (Diluted) 81.0M 83.2M 84.0M 84.6M 86.6M 86.7M 87.5M 88.5M
Dividends Per Share
← Newer Page 1 of 3 Older →